首页> 外国专利> COMPOSITION CONTAINING QUERCETIN FOR PREVENTING OR TREATING MALIGNANT PLEURAL MESOTHELIOMA OR AIDING TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA

COMPOSITION CONTAINING QUERCETIN FOR PREVENTING OR TREATING MALIGNANT PLEURAL MESOTHELIOMA OR AIDING TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA

机译:包含槲皮素的组合物,用于预防或治疗恶性胸膜间皮瘤或辅助治疗恶性胸膜间皮瘤

摘要

The present invention relates to a composition containing quercetin for preventing or treating malignant pleural mesothelioma or aiding treatment of malignant pleural mesothelioma. The composition for preventing or treating malignant pleural mesothelioma or aiding treatment of malignant pleural mesothelioma is characterized to containing quercetin. Quercetin regulates the expression of Sp1 regulatory gene such as Cyclin D1, Mcl-1, and Survivin in MS TO-211H cells. A cell death signal transduction is activates by isolating proteins, Bid, caspase-3, and PARP, reducing Bcl-xl, and increasing Bax in MSTO-211H cells. The result suggests that Sp1 is a novel molecular target of quercetin in malignant pleural mesothelioma. Therefore, quercetin can be used as an agent for preventing or treating malignant pleural mesothelioma or aiding treatment of malignant pleural mesothelioma.;COPYRIGHT KIPO 2014
机译:本发明涉及一种含有槲皮素的组合物,其用于预防或治疗恶性胸膜间皮瘤或辅助治疗恶性胸膜间皮瘤。用于预防或治疗恶性胸膜间皮瘤或辅助治疗恶性胸膜间皮瘤的组合物的特征在于含有槲皮素。槲皮素调节MS TO-211H细胞中Sp1调控基因如Cyclin D1,Mcl-1和Survivin的表达。细胞死亡信号转导通过在MSTO-211H细胞中分离蛋白质,Bid,caspase-3和PARP,还原Bcl-xl和增加Bax来激活。结果表明Sp1是恶性胸膜间皮瘤中槲皮素的新型分子靶标。因此,槲皮素可用作预防或治疗恶性胸膜间皮瘤的药物或辅助治疗恶性胸膜间皮瘤。; COPYRIGHT KIPO 2014

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号